Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nanosatellites see the light - laser communication for a new age in space

TESAT, KSAT and GomSpace have partnered up to introduce full optical communications capability for new innovative small satellite missions and space-based services. Until now this technology has mainly been used on large and expensive satellites but is now further developed, miniaturised and ready for use on small satellites and new constellations. The new technology will be launched in the PIXL demonstration mission later in 2019. The benefits of optical communications in space Optical communication technology offers a number of important benefits that will add to the value of

Adjusted comparison figures due to changes in business segments

On 1 March, Handelsbanken carried out a reorganisation which has meant that certain operations in the Handelsbanken Sweden and Handelsbanken Capital Markets business segments have been moved over to Group IT and the newly formed unit Group Products and Services. Income and expenses relating to Group IT and Group Products and Services are reported within Other units. At the same time, the model for the internal capital allocation to the business segments has been adjusted somewhat. Recalculated comparison figures for the past eight quarters are available at http://www.handelsbanken.se/

Additional patent protection for melflufen granted in the US until 2033

Stockholm - 10 April 2019 - Oncopeptides AB (Nasdaq Stockholm: ONCO) today announced that the US patent and trademark office has issued a notice that they intend to grant additional patents to Oncopeptides AB in the US. Oncopeptides has previously received the corresponding patent protection both in Japan and Europe.These patents (application numbers 14/438473 and 15/225323) protect, inter alia, the freeze-dried formulation. The patent protection extends to 2033. The freeze-dried preparation with melflufen is intended to be marketed at a future approval. “We have now approved formulation

MAG Interactive AB (publ) presents interim report Sep – Feb 2018/2019

Multiplayer games show continued revenue growth while user acquisition investments put pressure on the resultComment from CEO in summary “In line with our strategy multiplayer games are now growing steadily and represent about 70% of all revenues, up from less than 50% during the same period last year. Continued investments in performance marketing with good long-term returns, combined with improvements in our multiplayer games is the path back to profitability.”, says Daniel Hasselberg, CEO of MAG. “The negative result this quarter is an effect of user acquisition investments as the

Invitation to Kesko’s Q1/2019 interim report on 25 April 2019

A stock exchange release concerning Kesko Group’s Q1/2019 interim report will be published on Thursday, 25 April 2019, at about 9.00 (EET). Results conference, conducted in Finnish, will be held at 11.00 (EET) in Helsinki, Neptun building, Mannerheimintie 117. Coffee service available at 10.30. Webcast is available at www.kesko.fi/raporttikeskus. A transcript of the Q&A session will be available in English afterwards at www.kesko.fi/report-centre. An audiocast/teleconference, conducted in English, will be held at 14.00 (EET). A link to the audiocast/teleconference is available at www.

Corrected: Immunovia and University College of London sign agreement to expand validation studies of IMMray™ PanCan-d for early signs and symptoms

LUND, SWEDEN - Immunovia today announced that Prof. Stephen Pereira and his team at the institute for Liver and Digestive Health, University College London (UCL) will expand the prospective collection of blood samples funded by Immunovia and that started with the PanSYM-1 pilot study.The pilot PanSYM-1 study at UCL that started in 2017 (PR from November 2nd, 2017 ) is scheduled for readout in 2019 and, following today’s news, will now support the continuation of PanSYM-1 as a prospective validation study. The continued PanSYM-1 study

ChloraSolv receives CE marking and is cleared for commercial launch in EU

Gothenburg, Sweden, April 10th, 2019 – RLS Global AB announces that ChloraSolv, its wound care product targeting diabetic foot ulcers, has successfully obtained a CE marking based on confirmation from Lloyd’s Register, acting as Notified Body, and is therefore cleared in 32 European countries for commercialization.ChloraSolv is based on a Swedish innovation, which utilizes RLS Global’s proprietary buffered hypochlorite technology to debride and clean wounds to support the natural wound healing process. Clinical data has shown that ChloraSolv has unique properties with regards to cleansing

Fazer Group commits to cage-free eggs by 2024

Fazer is committed to using only cage-free eggs by 2024 in the Nordic and Baltic countries.Fazer’s commitment to cage-free eggs continues the company’s efforts in line with its sustainability approach and, especially, the core goal of 100% sustainably sourced. In Fazer’s revised sustainability approach, animal welfare was lifted as one of the essential topics, and the commitment to cage-free eggs supports the activities to be taken in this area. The commitment to cage-free eggs covers all Fazer’s businesses and countries of operation but, in the first phase, the focus will be on the Nordic

Aker Solutions and FSubsea to Create FASTSubsea to Boost Subsea Oil Recovery

April 10, 2019 - Aker Solutions and FSubsea have agreed to create FASTSubsea to help operators increase oil recovery in a faster, simpler and more environmentally friendly way. Multiphase subsea pumping technology has the potential to increase oil recovery rates by more than 20 percent, but cost, space limitations and sometimes complex solutions mean multiphase pumps are installed in fewer than 30 of the world's 1,500+ offshore fields. With FASTSubsea, this is about to change. The new company combines Aker Solutions' high-performance multiphase hydraulic technology with FSubsea's game-

Publishing of Valmet's Interim Review January - March 2019 on April 26, 2019

Valmet Oyj's press release on April 10, 2019 at 9:00 a.m. EET Valmet's Interim Review for January - March 2019 will be published on Friday, April 26, 2019 at approximately 9:00 a.m. Finnish time (EET). The stock exchange release and presentation material in Finnish and in English will be available at that time on Valmet's website at www.valmet.com/investors. News conference for analysts, investors and media Valmet will arrange a news conference in English for investment analysts, investors, and media on Friday, April 26, 2019 at 1:00 p.m. Finnish time (EET). The news conference

Diet rich in animal protein is associated with a greater risk of death

A diet rich in animal protein and meat in particular is not good for the health, a new study from the University of Eastern Finland finds, providing further backing for earlier research evidence. Men who favoured animal protein over plant-based protein in their diet had a greater risk of death in a 20-year follow-up than men whose diet was more balanced in terms of their sources of protein. The findings were published in the American Journal of Clinical Nutrition. Men whose primary sources of protein were animal-based had a 23% higher risk of death during the follow-up than men who had

The nomination committee´s proposal for the Board of Directors of SSM Holding

The nomination committee of SSM Holding AB (publ) proposes re-election of board members Anders Janson, Bo Andersson, Per Berggren, Sheila Florell, Ulf Morelius, Ulf Sjöstrand and Jonas Wikström. The nomination committee’s other proposals regarding remuneration, audit company etc. will be made public in the notice to the annual general meeting of SSM. The nomination committee’s statement to the annual general meeting 2019 will be made public on SSM’s corporate website no later than in connection with the notice. The nomination committee’s members are Johannes Wingborg (committee chair)

The road to registration in the US clarified

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the US Food and Drug Administration (FDA) during a pre-IND meeting is positive about the combination registration of IsoConDa and AnaConDa in the US. Sedana Medical now has a clear view of measures that have to be taken in order to reach marketing authorization approval of both IsoConDa and AnaConDa in the US. The meeting also confirmed Sedana Medical's estimate of the time and cost of a US approval that is expected to occur in 2024."The FDA has set clear requirements that are in line with the expectations we had, and they

New board members invest SEK 9.6 million in Brighter through a directed share issue.

IT entrepreneur and tech investor Emanuel Lipschütz and blockchain profile Tove Andersson, both of which have been proposed as new board members in Brighter for the Annual General Meeting in 2019, invest SEK 9.6 million through a directed share issue. Tove Andersson invests SEK 70,000 which is equivalent to the first year's board remuneration in Brighter. Tove Andersson is a prominent blockchain profile, founder of KryptoGäris, Scandinavia's largest crypto and blockchain network for women, and currently CMO of the blockchain company Superblocks. Emanuel Lipschütz invests SEK 9.5

DFDS offer passengers fast broadband from Nowhere Networks

The shipping company DFDS has chosen Swedish Nowhere Networks as its strategic supplier of fast broadband on all the six vessels operating the Dover-Calais and Dover-Dunkerque routes.After having successfully evaluated Nowhere Networks’ complete Wireless Antenna Tracking Solution DFDS has decided to proceed with a full rollout on all its ships operating the heavily trafficked routes in the English Channel. – Our evaluation has yielded impressive results which makes us highly confident in signing a strategic partnership with Nowhere Networks as our supplier of a fast-broadband capability.

Change in Management and Board of Directors.

The Nomination Committee of Brighter AB has proposed Truls Sjöstedt as new Chairperson of the Board and will endorse the proposal at the Annual General Meeting 2019. Truls is currently the company's CEO. The Board of Directors intends to appoint Henrik Norström, today COO, as CEO in connection with the Annual General Meeting on May 9. “During the last 12 years I have built and run the company. With the completion of Actiste, Brighter is facing a major commercial shift entering a new phase characterized by new challenges. I look forward to continuing to drive the company's top-level

Official notification of the annual general meeting.

Brighter AB (publ) will hold its Annual General Meeting (AGM) on Thursday 9th of May, at 11:00, at the offices of Brighter AB, Norgegatan 2 in Kista, Sweden. RIGHT TO PARTICIPATE AND REGISTRATION  Those who wish to participate in the Meeting must:  · Be registered as a shareholder in the shareholder register maintained by Euroclear Sweden AB by Friday 3rd of May 2019 and, · Inform the company of their intent to participate in the Meeting by Friday 3rd of May 2019 at the latest. Registration of participation must be made in writing to – preferably – ir@brighter.se, or by

Nordic Nanovector: Safety Review Committee Approves Advancing to Final Dosing Regimen in Phase 1 Trial of Betalutin® in DLBCL

Oslo, Norway, 10 April 2019 Nordic Nanovector ASA (OSE: NANO) announces that the Safety Review Committee (SRC) for the ongoing LYMRIT 37-05 clinical trial of single-administration Betalutin® (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) not eligible for stem cell transplantation (SCT) has now reviewed safety data from the first three cohorts of patients. Based on the data, the SRC approved advancing the trial to the next and final cohort with the dose regimen 20 MBq/kg Betalutin and a lilotomab pre-dose of 100 mg/m2. The

YIT has won several paving contracts in Finland, Sweden and Norway

YIT Corporation Investor News April 10, 2019 at 08.00 a.m.YIT has been successful in the competitive tendering early in the year and has won several government paving contracts in Finland, Sweden and Norway. Approximately EUR 70 million of the contracts won will be recorded in the order backlog for the first quarter of the year. The remaining part of the government paving contracts won will be recorded in the order backlog for the second quarter of the year. The following contracts will be recorded in the order backlog for the first quarter of the year. In Finland, YIT has won ELY

UPM Raflatac launches new film labeling solutions for APAC's rapidly growing POP-Up label market

(UPM Raflatac, Shanghai, 10 April 2019 at 12:00 CST) - UPM Raflatac is committed to delivering innovative, functional and high-performance film labels. It is now announcing the launch of the new eye-catching POP-Up labeling solutions for the APAC region. The labels attach to various packaging solutions as a 3D pop-up label on the top or side of products, enabling them to stand out from other competition on the shelves. These exceptional labeling solutions are applicable across multiple end-uses in the food, beverage, home care and personal care segments. Featuring clear, white

Board approval of the 2018 annual financial statements

The Board of Directors of Otello Corporation ASA has approved the consolidated financial statements, the parent company's financial statements and the Board of Directors' report for 2018. There are no material changes in compared with the Q4 2018 report released on February 28, 2019. The Board will propose to the Annual General Meeting, to be held on June 4, 2019, that no dividend for 2018 be paid out. Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com About Otello: Otello holds shares in several different businesses, including (i) AdColony which helps

Notice of extra general meeting in Biovica International AB

The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby invited to the extra general meeting on Thursday 2 May 2019 at 13.00 pm CET at Baker & McKenzie's premises at Vasagatan 7 in Stockholm. The doors to the meeting will open at 12.45 pm CET. Right to attend and notification Shareholders who wish to attend the extra general meeting must:         i.          on the record date, which is Thursday 25 April 2019, be registered in the share register maintained by Euroclear Sweden AB; and       ii.          notify the company of their

Biovica completes a directed new share issue of SEK 60 million and calls for an extraordinary general meeting

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Biovica International AB (publ) (”Biovica” or the ”Company”) has, subject to the extraordinary general meeting subsequent approval and as communicated in the Company’s press release

SDRL - Expiration of Tender Offer for 12.0% Senior Secured Notes due 2025

Hamilton, Bermuda, April 9, 2019 - Seadrill Limited (the "Company") announces the expiration of the cash tender offer for up to $311.1 million in aggregate principal amount of its 12.0% Senior Secured Notes due 2025 (the "Notes") pursuant to an offer to purchase, dated March 12, 2019.   The tender offer expired at 11:59 p.m., New York City time, on April 8, 2019 (the "Expiration Time").  Approximately $757.1 million in aggregate principal amount of the Notes, or approximately 98.5% of the amount outstanding, were validly tendered and not validly withdrawn. Of this amount, $311.1 million

There are no items matching the current filter
There are no more items matching the current filter
Back to top